Objective: Treatment of phenylketonuria (PKU) patients consists of a phenylalanine-restricted diet supplemented with a tyrosine-, vitamin-and oligoelement-enriched amino-acid mixture. Vitamins and oligoelements may be deficient when compliance with the supplemented special formula is poor. Plasma thiol concentrations (especially homocysteine) depend mainly on B-vitamin intake. Our aim was to evaluate the plasma thiol concentrations (homocysteine, cysteine and glutathione) and their determinants (methionine, cobalamin and folate) in PKU patients under dietary treatment compared with agematched controls. Design and setting: Cross-sectional study performed in a tertiary care Hospital. Subjects: PKU (42) patients under dietary treatment compared with 42 age-matched controls. Interventions: Plasma total homocysteine, cysteine and glutathione were analyzed by HPLC with fluorescence detection. Plasma phenylalanine and methionine were analyzed by ion exchange chromatography. Serum folate and cobalamin were analyzed by radioimmunoassay procedures. Results: Total homocysteine concentrations were significantly lower in the PKU patients compared with the control group (Students t-test; Po0.0001). Serum folate and cobalamin were significantly higher in the PKU group (t-Student; Po0.0001) compared with controls. A significantly negative correlation was observed between total homocysteine and folate (r ¼ À0.378; P ¼ 0.016), and between cobalamin and phenylalanine concentrations (r ¼ À0.367; P ¼ 0.022) in the PKU group. Conclusions: Plasma total homocysteine values are lower in the PKU group than in the controls, probably because of high folate values. High phenylalanine values, an indicator of poor dietary compliance, are negatively associated with cobalamin, which might be deficient in some cases.
Introduction
Phenylketonuria (PKU; McKusick 261600) is an inborn error of phenylalanine metabolism resulting from deficient activity of L-phenylalanine-4-monooxygenase (EC 1. 14.16.1), the enzyme that catalyzes the synthesis of tyrosine from phenylalanine (Scriver et al, 1995) . Treatment of PKU is traditionally based on a phenylalanine-restricted diet, which maintains plasma phenylalanine levels within a nontoxic range. The PKU diet consists of a reduced intake of natural proteins (mainly those of animal origin), which are replaced by special formulas that contain a Phe-free amino-acid mixture supplemented with tyrosine, vitamins and other micronutrients. This supplementation seems necessary to prevent micronutrient deficiencies (Acosta & Yannicelli, 1999) .
Oxidative stress is involved in the pathogenesis of several inborn errors of metabolism (Colome et al, 2000) . In PKU, deficiencies in two important antioxidants, selenium (Van Bakel et al, 2000) and coenzyme Q10 (Artuch et al, 1999) , have been reported. These deficiencies were mainly related to poor dietary compliance, and might cause an increase in peroxidative damage manifested in high malondialdehyde (MDA, a product of lipid peroxidation) values, low reduced glutathione concentrations and/or low normal tocopherol concentrations. This increased oxidative damage observed in PKU has led us to investigate other natural prooxidants (homocysteine) and antioxidants (total glutathione) that might be altered in PKU patients.
Homocysteine is an amino acid which naturally occurs in plasma and several tissues, and its concentration depends mainly on the balance between the remethylation and the transsulfuration pathways, with the first one depending in part on folate and cobalamin concentrations and the second on vitamin B 6 values (Guttormsen et al, 1996) . Suboptimal values of these vitamins have been related to several clinical and metabolic manifestations, such as neurological defects, megaloblastic anemia and hyperhomocysteinemia (Rosenblatt & Fenton, 2001) . As consistently reported, hyperhomocysteinemia has been associated with an increased risk of vascular disease and oxidative damage (Clarke et al, 1991; Loscalzo, 1996) . However, in spite of the growing importance of plasma homocysteine concentrations in human health, there have been no reports regarding the quantification of this amino acid in PKU, to our knowledge.
Transsulfuration pathway synthesizes cysteine from homocysteine. Cysteine has also recently been linked to increased risk of vascular disease (El-Khairy et al, 2001) . Moreover, cysteine is a precursor of glutathione, a tripeptide that plays a key role in detoxification of free radicals (Roediger, 1995) .
Our aim was to study plasma homocysteine and other thiol (cysteine and glutathione) concentrations in PKU patients under dietary treatment and their possible relation to (1) their main determinants: plasma methionine and serum cobalamin and folate values and (2) the dietary treatment compliance of patients evaluated as the median value of plasma phenylalanine concentrations during the last 6 months prior to the analysis (index of dietary control).
Subjects and methods
We studied 42 PKU patients (mean 15.3; s.d. 9.5 y) under dietary treatment and 42 control subjects of similar ages (median 15.7, s.d. 9.7 y). Control samples were collected from apparently healthy children (by history and analytical data) sent to our laboratory for analytical control before minor surgical interventions. All the patients were treated with a phenylalanine-restricted diet supplemented with a tyrosine-, vitamin-and other micronutrient-enriched amino acid mixture (Analog XP in infancy, Maxamaid XP in childhood, and Maxamum XP in adolescence and adulthood; Scientific Hospital Supplies, Barcelona, Spain). Plasma phenylalanine and methionine were analyzed by ion exchange chromatography with an LKB Biochrom 20 analyser (Pharmacia Biotech, Cambridge, England). The index of dietary control (IDC) was calculated as the average of the medians of plasma phenylalanine concentrations (Wendel et al, 1990) obtained every 6 months of metabolic monitoring of patients (phenylalanine was measured every 15 days on dried blood spot samples). All samples were obtained after a 10-h overnight fast.
Plasma total homocysteine (tHcy), total cysteine and total glutathione (the sum of the reduced and oxidized forms of these metabolites) were determined by high-performance liquid chromatography with fluorescence detection of the 7-fluorobenzo-2oxa-1,3-diazole-4-sulfonate derivatives (Vilaseca et al, 1997). Serum folate and cobalamin were determined by radioimmunoassay procedures (Gamma LKB Wallac 1272).
Informed consent for the study was obtained from the adult PKU patients, and from the parents of the PKU children. Samples from patients and controls were obtained in accordance with the Helsinki Declaration of 1964, as revised in 1996. The Ethics Committee of the Hospital Sant Joan de Déu approved the study.
Statistical methods: The Student's t-test was applied for statistical comparisons and the Pearson test for correlations. To avoid the confusing effects of the variables on plasma tHcy values, multiple linear regression analysis was applied among tHcy (as a dependent variable), age of patients, folate and cobalamin values (as independent variables). Statistical studies were performed with the SPSS program, version 10.0.
Results
Concentrations of plasma tHcy, methionine and total cysteine were significantly lower in the PKU patients compared with the control group (Table 1) , while total glutathione values were not different. Of 42 PKU patients 24 (57%) showed plasma tHcy concentrations below the lower limit established in our control population (4.6 mmol/l). Comparing serum folate and cobalamin concentrations, significantly higher values were observed in the PKU group compared with the control population (Table 1) .
Among the 42 PKU patients, 27 had acceptable dietary control (IDC values below 600 mmol/l: mean 335, s.d. 130 mmol/l) and 15 had poor dietary compliance (IDC values; mean 817, s.d. 152 mmol/l). Serum cobalamin values were significantly lower in the PKU patients on relaxed diet compared with the other PKU group, while folate and tHcy concentrations were not different ( Table 1) . The other variables studied were not different comparing the two PKU groups. Only two PKU patients, both of whom had poor dietary compliance, showed slightly decreased serum cobalamin values (129 and 136 pmol/l, respectively).
In the PKU group, a significantly negative correlation (Pearson test, Figure 1 ) was observed between tHcy and folate (r ¼ À0.378; P ¼ 0.016), and positive between tHcy and age (r ¼ 0.564; Po0.0001) and between tHcy and total cysteine (r ¼ 0.462; P ¼ 0.002). No correlation was observed between cobalamin values and plasma tHcy concentrations. The IDC positively correlated with age (r ¼ 0.441; P ¼ 0.004) and negatively with cobalamin concentrations (r ¼ À0.367; P ¼ 0.022). To assess the influence of patient age and serum folate and cobalamin levels on plasma tHcy concentrations, multiple linear regression analysis was applied ( Table 2 ). The association between homocysteine and age or folate values was confirmed, while no correlation was observed between homocysteine and cobalamin values.
Discussion
The natural protein restricted diet of PKU patients may result in some essential nutrient deficiencies; ie selenium (Van Bakel et al, 2000) or cobalamin (Hanley et al, 1996) . To prevent these deficiencies, supplementation with several of these micronutrients has been added to the special formulas.
One of the problems that arises in the chronic dietary treatment of PKU patients is the lack of adherence to the restricted diet among adolescents and adults, resulting in deficient levels of these micronutrients (Brenton & Pietz, 2000) . These deficiencies might cause some metabolic disturbances, such as dysfunction in several antioxidant defences thereby causing an increased oxidative stress (Darling et al, 1992; Sierra et al, 1998) . Thiol status, a wellrecognized factor associated either with increased oxidative damage (high plasma and tissue tHcy values) or antioxidant properties (glutathione), has not been reported in PKU, to our knowledge.
According to our results, tHcy was significantly lower in our PKU patients than in controls. Decreased tHcy levels would be related to dietary restriction or to B-vitamin supplementation. Folate is one of the main nutritional determinants of tHcy levels (Rosenblatt & Fenton, 2001) , and its values were significantly higher in PKU than in the control population. These data, together with the negative correlation observed between folate and tHcy (both in simple correlation and in multiple linear regression corrected by age), support a role for folate in the reduction of tHcy concentrations in the PKU population.
Cobalamin deficiency was reported in adolescent and adult PKU patients (Hanley et al, 1996) and therefore supplementation with this vitamin is routinely performed in their dietary management. In fact, an increased risk of cobalamin deficiency was documented in PKU patients with poor compliance with the cobalamin-supplemeted formula (Robinson et al, 2000) . Interestingly, cobalamin values were significantly lower in the PKU group with a poor dietary compliance compared with PKU patients under restricted diet, supporting the data previously reported by other authors (Robinson et al, 2000) . However, serum folate and plasma tHcys values were not different comparing the two PKU groups, suggesting that folate is probably a more important determinant than cobalamin in tHcy values, at least in our PKU patients. Moreover, our data suggest that tHcy determination would not be useful for detecting a possible cobalamin deficiency in our PKU patients, because high folate levels would maintain homocysteine values in the low control range. Methylmalonic acid would thus be the best marker for these patients.
Interestingly, two of our patients presented with a mild cobalamin deficiency. One of them showed a low tHcy value (3.7 mmol/l), with high folate levels (48.4 nmol/l). Conversely, although normal, the other patient showed the highest tHcy (8.6 mmol/l) together with the lowest folate value (27.9 nmol/l) among the PKU patients. These data reinforce the hypothesis that folate levels mainly determine tHcy concentrations, which are low normal even in the presence of suboptimal cobalamin values. Vitamin B 6 is another determinant of plasma tHcy concentrations (Siri et al, 1998) . Unfortunately, we could not measure it in this study, although this vitamin is also routinely supplemented in the PKU treatment. In fact, the daily intake of this vitamin in our PKU is slightly higher than the RDAs (data not shown). Vitamin B 6 supplementation in PKU patients probably allows a rapid elimination of tHcy through the transsulfuration pathway. Furthermore, the positive correlation observed between tHcy and total cysteine concentrations would further support this hypothesis.
Another explanation for the low tHcy concentrations in our PKU patients might be the reduced natural-protein intake (Schneede et al, 2000) . In fact, plasma methionine values in PKU were lower than those for controls, although mean differences were not as noteworthy as those observed for tHcy values, and they probably have no clinical significance. Furthermore, there was no correlation between methionine and tHcy concentrations in PKU patients.
Methionine is an essential amino acid that plays a key role in several biological processes, such as synthesis of protein, acetyl-CoA and glutathione (Roediger, 1995) . It has been demonstrated in some diseases that methionine deficiency causes decreased glutathione synthesis (Roediger, 1995) , bringing on increased oxidative stress. The normal values for total glutathione observed in PKU patients reinforce the idea that these decreased methionine values might have no clinical significance. However, remethylation of homocysteine to methionine might be impaired in PKU patients with low folate or cobalamin stores, causing decreased values of this essential amino acid, which might have clinical significance in patients with bad dietary compliance.
Total cysteine concentrations were also lower in PKU than in the controls, although (as occurs with methionine) the differences between patients and controls were very slight and probably without clinical significance. The fact that total glutathione values were not different from those for the control population would tend to support this statement.
Glutathione is a free radical scavenger the main nutritional source of which is the sulfur amino acids cysteine and methionine (White et al, 1994) . Glutathione plays a pivotal role in free radical detoxification, and deficiencies in this molecule have been associated with increased oxidative damage related with the pathophysiology of several diseases Plasma thiols in phenylketonuria C Colomé et al (White et al, 1994) . The normal values for glutathione observed in the present study, together with the normal glutathione peroxidase activities observed in previous studies in PKU patients supplemented with selenium (Wilke et al, 1992) , would suggest that the glutathione system will function in a correct way in this disease if good metabolic control is achieved.
Dietary adherence in PKU is a hot topic, especially in adolescent and adult PKU patients. According to our results, low tHcy and cysteine concentrations in PKU patients might be associated with a decreased risk of developing vascular disease. Although tHcy values were low in our series, even in patients with a poor metabolic control, the lower values of cobalamin observed in the latter group argues in favor of the advisability of the maintenance of a restricted diet as much as possible. Furthermore, the normal glutathione values observed in our PKU patients would further support the beneficial effects of low tHcy and cysteine concentrations. However, this hypothesis should be considered with caution because other factors present in PKU patients may increase oxidative stress, such as selenium deficiency in patients with poor dietary adherence (Van Bakel et al, 2000) , or the decreased ubiquinone-10 values observed in serum (Artuch et al, 1999) and cells (Colomé et al, 2002) .
In conclusion, plasma tHcy values are decreased in PKU, probably as a consequence of high folate values, while total glutathione values are in the control range. The adherence to the special formula seems important in preventing suboptimal cobalamin status. Taking all these data together, thiol and B-vitamin status in closely monitored PKU patients might have a protective effect against vascular disease and other complications probably derived from chronic dietary treatment.
